PROFILE OF NONFERMENTING GRAM NEGATIVE BACILLI IN A TERTIARY CARE HOSPITAL LABORATORY

Main Article Content

Dr Lopamudra
Dr Aruna Rani Behera
Dr Swetalina Jena
Dr Dibya Prasana Mohanty

Keywords

.

Abstract

Introduction: Non-Fermentative or Non Fermenting Gram Negative Bacilli (NFGNB) are widely distributed in nature as saprophytes, found in soil, water, sewage or as commensals on human skin or in the human gut and some in hospital environment. These organisms are commonly isolated from patients with serious underlying diseases such as patients with prolonged antibiotic therapy, endotracheal intubation, catheterization, burn patients and in extremes of age like neonates, children and geriatrics age group. They are responsible for septicemia, meningitis, brain abscess, endocarditis, pneumonia, urinary tract infection and surgical site infections.


Materials and Methods: This a prospective study, conducted in the Department of Microbiology, VSS Medical College & Hospital, Burla over a period of two years from October 2014 to September 2016. A total of 9204 non repetitive clinical specimens like sputum, throat swabs, endotracheal tube secretions, pus, urine, blood, and body fluids were collected using strict aseptic precautions from various clinical departments and immediately processed.


Observation & Results: In this study 9204 clinical samples were processed in Microbiology Laboratory, out of which 3955 specimens showed growth; 571 of these positive cases showed mixed cultures of two organisms. Hence total number of isolates summed upto 4526, including 1350 isolates of gram-negative bacilli. Out of these, 505 cases are found to be nonfermenters. Pseudomonas aeruginosa is the most common isolate accounting for 349 (69.30%) followed by Acinetobacter baumanii 84(16.63%) and next to it is Pseudomonas fluorescens 42(7.92%). The maximum number of cases are from Surgery ward accounting for 26.53% followed by Medicine ward 20.39% and 17.82% from Obstetrics and Gynaecology ward. The most effective drugs against Pseudomonas aeruginosa isolates showed sensitivity to Meropenem (78%) followed by Imipenem (73.56%) and Amikacin (51.23%). A.baumannii isolates showed highest sensitivity to meropenem (76%) followed by imipenem(74%) and chloramphenicol(62%)., S.maltophila showed 100% resistance to ceftazidime and cefotaxime, but 100% sensitive to amikacin, imipenem, meropenem, aztreonam, and ciprofloxacin.


Conclusion: Most of the NFGNB are resistant to commonly used antibiotics, hence antibiogram should be followed before successfully treating these cases. Above all, the Hospital Infection Control Committee should be active enough to avoid infections due to NFGNB as well as other organisms and the Hospital Antibiotic Policy should be followed strictly.

Abstract 71 | pdf Downloads 42

References

1. Jawetz , Melnick And Adelbergs Medical Microbiology
2. Koneman Ew, Alen Sd, Janda Wm, Schreckenbeiger Pc,Winn Wc. The Non Fermenting Gramnegative Bacilli. Color Atlas And Text Book Of Diagnostic Microbiology.5th Edition, Philadelphia: J.B.Lippincott, 1997;253-309.
3. Steinberg Jp , Rio Dc. Gram Negative and Gram Variable Bacilli. Principles And Practice Of Infectious Diseases 2005;2:2751-68.
4. Gales Ac,Jones Rn,Forward Kr,Linaes J,Sader Hs,Verhoef J.Emerging Importance Of Multidrug Resistant Acinetobacter Species And S maltophila As Pathogens In Seriously Ill Patients: Genetic Patterns, Epidemiological Features And Trends In The Sentry Antimicrobial Surveillance Program. Clinical Infectious Disease 2001;32:104-13.
5. Fujita J, Negayama K, Fujita T Et Al. Activity Of Antibiotics Against Various Stains Of Clinically Isolated Glucose Nonfermenting Gram Negative Bacteria J Intern Med 1991;6:553-555.
6. Noberto Jp. Pseudomonas. In:Borriello Sp,Murray Pr, Funke G. Microbiology And Microbial Infections. 10th Edition Washingtondc: American Society For Microbiology;2005.P.16-1606.
7. Rubi Sj,Granto Pa,Wasilauskas Bl. Glucose Nonfermenting Gram Negative Bacteria. In: Lenna,Hausler Wj Jr, Shadomy Hj. Manual Of Clinical Microbiology 4th Edition.Washington Dc : American Society For Microbiology; 1985.P.330- 49.
8. Edith Bh, Deborah Ah ,Speert Dp. Pseudomonas . In: Baron Ej, Jorgensen Jh ,Landry Ml,Pfaller Ml. Manual Of Clinical Microbiology . 9th Ed. Washington Dc: American Society For Microbiology ; 2007.P.734-48.
9. Livermore Dm. Beta-Lactamases In Laboratory And Clinical Resistance. Clinical Microbiology Rev8;1995:557-84.
10. Livermore Dm. Multiple Mechanisms Of Antimicrobial Resistance In Pseudomonas aeruginosa. Clinical Inf Disease2002; 34:634-40.
11. Krisztina M. Papp-Wallace,1,2 Andrea Endimiani,1,2,3 Magdalena A. Taracila,2 And Robert A. Bonomo1,2,4,5, Carbapenems: Past, Present, And Future. Antimicrobial Agents Chemotherapy. 2011 November; 55(11): 4943–4960.
12. Ryan S. Arnold, Md, Kerri A. Thom, Md, Ms, Saarika Sharma, Md, Ma, Michael Phillips, Md, J. Kristie Johnson, Phd, Daniel J. Morgan, Md, Emergence Of Klebsiella pneumoniae Carbapenemase-Producing Bacteria. South Med J. 2011;104(1):40-45.
13. Malini A, Deepak, Gokul Bn, And Prasad Sr Nonfermenting Gram-Negative Bacilli Infections In A Tertiary Care Hospital In Kolar, Karnataka,J Lab Physicians. 2009 Jul-Dec; 1(2): 62–66.
14. Parimal H Patel, Dr.Jayshree D Pethani , Dr.Sanjay D Rathod , Dr.Bimal Chauhan , Dr.Parul D Shah , Prevalence Of Nonfermenting Gram Negative Bacilli Infection In Tertiary Care Hospital Indian Journal Of Basic & Applied Medical Research; March 2013: Issue-6, Vol.-2, P. 608 – 613.
15. Rit K,Nag F, Rar Hj, Maity Pk. Prevalence And Susceptibility Profiles Of Nonfermentative GNB In A Tertiary Care Hospital Of Eastern India. Indian Journal Of Clinical Practice 2013 ;24(5):451-5.
16. Gardener P, Griffin Wb, Swartz Mn, Kunz Lj. Nonfermenting Gram- Negative Bacilli Of Nosocomial Interest. Amer J Med 1970; 48:735-749.
17. Pickett MJ, Pedersen MM. Nonfermentative Bacilli Associated with man:II. Detection and Identification. Amer J Clin Path 1970; 54:164-177.
18. Yashodhara P. Shyamala S. Identification and characterization of Nonfermenters from Clinical Specimens. IJMM 1997; 15: 195-197.
19. Dheepa Muthusamy, Appalaraju Boppe, Phenotypic Methods for the detection of various Betalactamases in carbapenem resistant isolates Of Acinetobacter baumanii at a Tertiary Care Hospital In South India, Journal Of Clinical And Diagnostic Research, 2012, Aug Vol 6, Issue 6 ,Page 970-973.
20. Mehmish Za, Shibl Am, Kambal Am, Ohlay Ya, Ishaq Am, Livermore Dm, Antimicrobial Resistance Among NFGNB In Saudi Arabia. Jour Of Antimicrobial Chemotherapy 2012;67(7):1701-5.
21. Pathi B, Mishra Sn, Panigrahi K, Poddar N, Lenka Pr, Mallick B, Et Al. Prevalence And antibiogram pattern of Pseudomonas aeruginosa. In A Tertiary Care Hospital From Odisha, India. Transworld Medical Journal2014; (3):77-80.
22. Quinn Jp. Clinical Problems Posed By Multiresistant Nonfermentating Gram Negative Pathogens. Clinical Infectious Diseases 1998; 27:117-124.
23. Agrawal G , Lodhi Rb , Kamalakar Up, Khadse Rk , Jalgaonkar Sv, Study Of Metallo-Β-Lactamase production in Clinical Isolates Of Pseudomonas aeruginosa Year : 2008 | Volume : 26 | Issue : 4 | Page : 349-351
24. Nagoba Bs, Deshmukh Sr,Wadher Bj, Gude Ug, Gomashe Av, Tumane Pm. Induction Of Resistance To ciprofloxacin And Other fluoroquinolones In clinical And Environmental Isolates Of Pseudomonas aeruginosa. Ind J Med Microbiology 1998; 16:29-30
25. Taneja N, Maharwal S,Sharma M. Imipenem Resistant In Nonfermenters Causing Nosocomial Urinary Tract Infection. Ind J Med Sci 2003; 57:294-299.
26. Sarkar B, Biswas D, Prasad R, Sharma Jp. A Clinico-microbiological Study On The Importance Of Pseudomonas In Nosocomially Infected ICU patients, With Special Reference To Metallo-β-Lactamase Production. Ind J Pathol Microbiol 2006; 49:44-48.
27. Dheepa Muthusamy, Appalaraju Boppe, Phenotypic methods for detection of various betalactamases in carbapenem resistant isolates of Acinetobacter baumanii at a Tertiary Care Hospital in South India, Journal of Clinical and diagnostic Research,2012,Aug Vol 6, Issue 6 Page 970-973.
28. Lautenbach E, Synnestvedt M, Weiner Mg, Bilker Wb, Vo L, Schein J, Kim M Epidemiology and impact Of imipenem resistance in Acinetobacter baumannii. Infect Control Hosp Epidemiol. 2009 Dec;30(12):1186-92.
29. Alonso A And Martínez Jl, Multiple Antibiotic resistance in Stenotrophomonas maltophilia. Antimicrobial. Agents Chemotherapy. May 1997 Vol. 41 No. 5 1140- 1142

30. Patil Jr, Jog Nr, Chopade Ba. Isloation And Characterization Of Acinetobacter spp. from Upper Respiraory Tract Of Healthy Humans And Demonstration Of Lectin Activity. Ind J Med Microbiol 2001;19:30-35.
31. Forbes Ba, Sahm Df, Weissfeld As. Pseudomonas, Burkholderia And Similar Organism in Diagnostic Microbiology. 10th Edition, Baltimore:Mosby, 1998;448- 461
32. Daniel Ct, Chang Sc, Chen Yc Et Al , In Vitro Activities Of Antimicrobial Agents , alone and in combinations against Burkholderia cepacia isolated from blood, Diagnostic Microbial Diseases ,1997;28:187-191